Persistence and Efficacy of Maternal COVID-19 Vaccine-Induced Antibodies in Human Milk: A Comprehensive Meta-Analysis
Analyzing the Durability and Impact of COVID-19 Vaccine Antibodies in Breast Milk
DOI:
https://doi.org/10.69750/dmls.01.02.022Keywords:
COVID-19; SARS-CoV-2; antibodies; human milk; maternal vaccination; passive immunity; breastfeeding; IgA; IgG; meta-analysis.Abstract
Abstract
Background: The ongoing global health challenge posed by the COVID-19 pandemic has necessitated a thorough examination of vaccine efficacy, particularly the transfer of vaccine-induced immunity to infants via human milk. This meta-analysis aims to explore the persistence and efficacy of COVID-19 vaccine-induced antibodies in human milk, offering insights into passive immunity transfer to breastfeeding infants.
Methods: We conducted a systematic review and meta-analysis of peer-reviewed studies published from January 2021 to December 2023, extracted from databases such as PubMed, Scopus, and Web of Science. Our focus was on studies measuring SARS-CoV-2-specific antibodies (IgA and IgG) in human milk following maternal COVID-19 vaccination.
Results: Fifteen studies involving 1,200 lactating mothers who received mRNA COVID-19 vaccines were included. The analysis highlighted a consistent presence of SARS-CoV-2-specific IgA and IgG antibodies in human milk, persisting for up to six months post-vaccination.
Conclusion: The results highlight the noteworthy transmission of COVID-19 antibodies via human milk, suggesting an extended duration of possible protection for neonates against SARS-CoV-2 infection. This argues in favor of immunizing nursing mothers as a preemptive public health strategy to provide their children passive immunity.
Downloads
References
Hunagund S, Golan Y, Asiodu IV, Prahl M, Gaw SL. Effects of vaccination against influenza, pertussis, and COVID-19 on human milk antibodies: current evidence and implications for health equity. Front Immunol. 2022;13:910383.
Kurniawati EM, Rahmawati NA. Records of antibodies in breast milk in postpartum women vaccinated or exposed to COVID-19: a systematic review. F1000Res. 2022;11:785.
Mardiyan Kurniawati E, Rahmawati NA. Records of antibodies in breast milk in postpartum women vaccinated or exposed to COVID-19: a systematic review. F1000Res. 2022;11:785.
De Rose DU, Salvatori G, Dotta A, Auriti C. SARS-CoV-2 vaccines during pregnancy and breastfeeding: a systematic review of maternal and neonatal outcomes. Viruses. 2022;14(3):539.
Nicolaidou V, Georgiou R, Christofidou M, Felekkis K, Pieri M, Papaneophytou C. Detection of SARS-CoV-2–specific antibodies in human breast milk and their neutralizing capacity after COVID-19 vaccination: a systematic review. Int J Mol Sci. 2023;24(3):2957.
Devera JL, Gonzalez Y, Sabharwal V. A narrative review of COVID-19 vaccination in pregnancy and breastfeeding. J Perinatol. 2024;44(1):12-9.
Dimitroglou M, Sokou R, Iacovidou N, Pouliakis A, Kafalidis G, Boutsikou T, et al. Anti-SARS-CoV-2 immunoglobulins in human milk after coronavirus disease or vaccination: time frame, duration and factors affecting titers. Nutrients. 2023;15(8):1905.
Falsaperla R, Leone G, Familiari M, Ruggieri M. COVID-19 vaccination in pregnant and lactating women: a systematic review. Expert Rev Vaccines. 2021;20(12):1619-28.
Jorgensen SC, Burry L, Tabbara N. Role of maternal COVID-19 vaccination in providing immunological protection to the newborn. Pharmacotherapy. 2022;42(1):58-70.
Shook LL, Edlow AG. Safety and efficacy of COVID-19 mRNA vaccines during lactation. Obstet Gynecol. 2023;141(3):483-91.
Pham A, Aronoff DM, Thompson JL. Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity. J Allergy Clin Immunol. 2021;148(3):728-31.
Ricciardi A, Zelini P, Cassaniti I, Avanzini MA, Colaneri M, De Silvestri A, et al. Serum and breastmilk SARS-CoV-2 antibodies following BNT162b2 vaccine: prolonged protection in newborns and older children. Int J Infect Dis. 2022;122:905-9.
Chaubey I, Vijay H, Govindaraj S, Babu H, Cheedarla N, Shankar EM, et al. Impact of COVID-19 vaccination on pregnant women. Pathogens. 2023;12(3):431.
Shook LL, Fallah PN, Silberman JN, Edlow AG. COVID-19 vaccination in pregnancy and lactation: current research and gaps. Front Cell Infect Microbiol. 2021;11:735394.
Dimitroglou M, Sokou R, Iacovidou N, Pouliakis A, Kafalidis G, Boutsikou T, et al. Anti-SARS-CoV-2 immunoglobulins in human milk after COVID-19 disease or vaccination: systematic review. Nutrients. 2023;15:1905.
Liu S, Zhong J, Zhang D. Transplacental transfer of maternal antibody against SARS-CoV-2 and its influencing factors: a review. Vaccines (Basel). 2022;10(7):1083.
Valcarce V, Stafford LS, Neu J, Cacho N, Parker L, Mueller M, et al. Detection of SARS-CoV-2 IgA in human milk of vaccinated lactating health workers. Breastfeed Med. 2021;16(12):1004-9.
Cassidy AG, Li L, Golan Y, Gay C, Lin CY, Jigmeddagva U, et al. Adverse reactions, antibody patterns and 12-month outcomes after maternal COVID-19 mRNA vaccination. JAMA Netw Open. 2023;6(7):e2323405.
Ismail SR. SARS-CoV-2 antibodies in human milk: validation of methods and response to infection and vaccination. Univ Toronto; 2022.
Ware J, McElhinney K, Latham T, Lane A, Dienger-Stambaugh K, Hildeman D, et al. Sustained and boosted antibody responses in breast milk after maternal SARS-CoV-2 vaccination. Breastfeed Med. 2023;18(8):612-20.
Bender JM, Lee Y, Cheng WA, Marentes Ruiz CJ, Pannaraj PS. COVID-19 vaccine booster effects seen in human milk antibody response. Front Nutr. 2022;9:898849.
Perez SE, Luna Centeno LD, Cheng WA, Marentes Ruiz CJ, Lee Y, Congrave-Wilson Z, et al. Human milk SARS-CoV-2 antibodies up to 6 months after vaccination. Pediatrics. 2022;149(2):e2021056049.
Calil VMLT, Palmeira P, Zheng Y, Krebs VLJ, Carvalho WB, Carneiro-Sampaio M. CoronaVac induces anti-SARS-CoV-2 IgA in human milk. Clinics (Sao Paulo). 2021;76:e3185.
Esteve-Palau E, Gonzalez-Cuevas A, Guerrero ME, Garcia-Terol C, Alvarez MC, Garcia G, et al. SARS-CoV-2 antibodies in breast milk after Pfizer-BioNTech vaccination. medRxiv. 2021:2021.11.11.21266119.
Shuja A, Shahbaz MN, Sharif S, Ikram A, Shuja MS, Shuja NS. Investigating diagnostic and therapeutic role of lncRNA MALAT1 in breast carcinoma: in silico study. Dev Med Life Sci. 2024;1(1).
Shuja A, Abubakar M, Shahbaz MN, Shahid SS, Khosa MM. Role of nano-enzyme in diagnosis, prognosis and treatment of GIT cancer. Dev Med Life Sci. 2024;1(1).
Haq Z, Zaidi SUS, Shahid MN, Waseem AB, Tahir I, Munir M, et al. Impact of high BMI on cholesterol and type-2 diabetes control: a cross-sectional study. Dev Med Life Sci. 2024;1(1).
Henle AM. Increase in SARS-CoV-2 RBD-specific IgA and IgG in human milk after COVID-19 booster vaccination. J Hum Lact. 2023;39(1):51-8.
Juncker HG, Mulleners SJ, van Gils MJ, de Groot CJ, Pajkrt D, Korosi A, et al. Levels of SARS-CoV-2 antibodies in human milk after vaccination. J Hum Lact. 2021;37(3):477-84.
Kelly JC, Carter EB, Raghuraman N, Nolan LS, Gong Q, Lewis AN, et al. Anti-SARS-CoV-2 antibodies induced in breast milk after Pfizer-BioNTech vaccination. Am J Obstet Gynecol. 2021;225(1):101-3.
Lebbe B, Reynders M, Van Praet J. Transfer of vaccine-generated SARS-CoV-2 antibodies into infant circulation via breast milk. Int J Gynaecol Obstet. 2022;158(2):478-80.
Narayanaswamy V, Pentecost BT, Schoen CN, Alfandari D, Schneider SS, Baker R, et al. Neutralizing antibodies and cytokines in breast milk after COVID-19 mRNA vaccination. Obstet Gynecol. 2022;139(2):181-91.
Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E, et al. SARS-CoV-2 antibodies in breast milk after vaccination. JAMA. 2021;325(19):2013-4.
Downloads
PlumX Metrics
Published
Issue
Section
License
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
How to Cite
